Phase II study tested combination of sacituzumab govitecan plus pembrolizumab ...

Data from the IMvigor011 phase 3 study shows that adjuvant atezolizumab (Tecentriq) significantly boosts the reduction and clearance of circulating tumor DNA (ctDNA). Presented at ...

"We found CKD to be independently associated with a higher likelihood of nonorgan confined disease and lymph node metastases as well as postoperative transfusion and 90-day readmissions." – Nguyen, et ...

PATIENTS AND METHODS: All patients undergoing radical cystectomy with bilateral pelvic iliac lymphadenectomy, with the intent to cure, for transitional-cell carcinoma of the bladder between July 1971 ...

BEIJING, Sept. 24, 2020 -- Professor Niu Haitao with the Affiliated Hospital of Qingdao University performs a remote radical cystectomy on a patient 3,000 kilometers away with the help of a ...

This transcript has been edited for clarity. Cheryl Lee, MD: Welcome to Medscape InDiscussion. I'm Cheryl Lee, and today we'll be discussing a topic that has continued to be controversial. I'm ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced it will present new ...

After the bladder is surgically removed and the urinary system diverted, most can return to their usual activities. When William O’Brien was diagnosed with bladder cancer at 75, he fit the profile of ...